Alzheimer's and Dementia
Alzheimer's and Dementia is a journal indexed in SJR in Epidemiology and Neurology (clinical) with an H index of 178. It has an SJR impact factor of 3,6 and it has a best quartile of Q1. It has an SJR impact factor of 3,6.
Alzheimer's and Dementia focuses its scope in these topics and keywords: disease, alzheimers, cognitive, dementia, pet, study, screening, patients, tau, alzheimer’s, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
3,6
H-index
178
Docs (year)
729
Docs 3y
1635
Total refs
42001
Cites 3y
11241
Citable 3y
1115
Cites/Doc 2y
6.85
Ref/Doc
57.61
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Centers for Medicare and Medicaid Services proposes new telehealth services for Medicare beneficiaries
View moreWorldwide Alzheimer's Disease Neuroimaging Initiative
View moreDiagnosis and assessment of Alzheimer's disease in diverse populations
View moreDevelopment of a straightforward and sensitive scale for MCI and early AD clinical trials
View moreCurrent and past leisure time physical activity in relation to risk of Alzheimer's disease in older adults
View moreComputerized diagnosis of mild cognitive impairment
View moreCommunity perceptions related to brain donation: Evidence for intervention
View moreCommentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective
View moreCognitive changes and dementia risk after traumatic brain injury: Implications for aging military personnel
View moreCloser caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression Study
View moreCerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease
View moreCerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults
View moreCerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
View more[O1-03-06]: Human amyloid-imaging studies with Pittsburgh Compound-B in mild cognitive impairment (MCI): Is MCI the critical period of amyloid plaque deposition?
View moreBlood DNA methylation as a potential biomarker of dementia: A systematic review
View moreAustralian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010
View moreApolipoprotein E genotype and the association between C-reactive protein and postoperative delirium: Importance of gene-protein interactions
View moreAlzheimer's disease: The next frontier - Special Report 2017
View moreAlzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation
View moreAdherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2
View more[P4-216]: COMPARISON OF GRAY MATTER VOLUME AND FRACTIONAL ANISOTROPY IN MILD COGNITIVE IMPAIRMENT PATIENTS WITH AND WITHOUT AMYLOIDOPATHY
View more[P3-528]: PROSPECTIVE ASSOCIATIONS BETWEEN VITAMINS, METABOLITES, AND OVERALL DEMENTIA IN THE OLDEST-OLD
View more[P3-191]: SLEEP PROBLEMS AND CHANGES IN AD BIOMARKERS ARE PREDICTIVE OF PERSONS WHO ULTIMATELY DEVELOP AD: FINDINGS FROM SUBGROUP META-ANALYSIS ON SLEEP AND ALZHEIMER's DISEASE
View more[P2-301]: DISEASE STAGING IN FRONTOTEMPORAL DEMENTIA AND ALZHEIMER'S DISEASE: THE CONTRIBUTION OF THE FRONTOTEMPORAL DEMENTIA RATING SCALE (FTD-FRS) IN A 12-MONTH FOLLOW-UP STUDY
View more